FTC sues key pharmacy profit professionals above insulin price ranges The agency brought motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list cost of lifestyle-saving insulin drugs. Insurers will continue on vertically integrating to maintain much more profits https://knoxwnduk.daneblogger.com/30033168/not-known-factual-statements-about-healthcare-news